Review



bromoadenosine 3  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Thermo Fisher bromoadenosine 3
    Bromoadenosine 3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromoadenosine+3/8-Bromoadenosine-3'%2C5'-cyclic+monophosphate/pm41699681-111-14-17
    Average 94 stars, based on 1 article reviews
    bromoadenosine 3 - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    FACS:

    Article Title: Derivation of Epithelial-Only Airway Organoids from Human Pluripotent Stem Cells
    Article Snippet: .. FACS buffer 49.5 mL 1× phosphate buffered saline 0.5 mL fetal bovine serum (e.g. Gibco, cat. no. 10082139) Sort buffer 50 mL FACS buffer 50 μL 10 mM Y-27632 10× cAMP/IBMX Stock 50 mL cSFDM base 21.5 mg 8-Bromoadenosine 3’,5’-cyclic monophosphate sodium salt (cAMP, Sigma-Aldrich, cat. no. B7880-100MG) 500 uL 0.1 M IBMX (3-isobutyl-1-methylxanthine, Sigma, cat. no. I5879) Filter sterilize and store at 4°C for up to 1 month. .. 250 μg/mL recombinant human FGF2 1 mg recombinant human FGF basic protein (R&D Systems cat. no. 233-FB-025) 4 mL 0.1% BSA Prepare 0.1% BSA in PBS by diluting 13 μ L Bovine Albumin Fraction V, 7.5% solution in 1 mL PBS .

    Saline:

    Article Title: Derivation of Epithelial-Only Airway Organoids from Human Pluripotent Stem Cells
    Article Snippet: .. FACS buffer 49.5 mL 1× phosphate buffered saline 0.5 mL fetal bovine serum (e.g. Gibco, cat. no. 10082139) Sort buffer 50 mL FACS buffer 50 μL 10 mM Y-27632 10× cAMP/IBMX Stock 50 mL cSFDM base 21.5 mg 8-Bromoadenosine 3’,5’-cyclic monophosphate sodium salt (cAMP, Sigma-Aldrich, cat. no. B7880-100MG) 500 uL 0.1 M IBMX (3-isobutyl-1-methylxanthine, Sigma, cat. no. I5879) Filter sterilize and store at 4°C for up to 1 month. .. 250 μg/mL recombinant human FGF2 1 mg recombinant human FGF basic protein (R&D Systems cat. no. 233-FB-025) 4 mL 0.1% BSA Prepare 0.1% BSA in PBS by diluting 13 μ L Bovine Albumin Fraction V, 7.5% solution in 1 mL PBS .

    Transferring:

    Article Title: Generation and expansion of transitional lung organoids from human pluripotent stem cells
    Article Snippet: .. The plate was placed in normoxic incubator for 30 minutes until Matrigel polymerized and 1 ml of CKDCI (3μM CHIR 99021, 10 ng/ml rhKGF, 50 ng/ml dexamethasone (ThermoFisher), 0.1 mM 8-Bromoadenosine 3’,5’-cyclic monophosphate sodium salt (Tocris) and 0.1 mM 3-Isobutyl-1-methylxanthine (Sigma-Aldrich)) media was gently added using 10 ml serological pipette. ..

    Droplet Countercurrent Chromatography:

    Article Title: Transcriptomic profiling analysis of human endometrial stromal cells treated with autologous platelet‐rich plasma
    Article Snippet: .. Four days after scratching, two culture dishes with and without PRP treatment were maintained in DMEM/F12 without phenol red (Thermo Fisher Scientific) containing 2% (v/v) DCC‐FBS and treated with 0.5 mM 8‐bromoadenosine 3′,5′‐cyclic adenosine monophosphate (8‐bromo‐cAMP) and 1 μM progesterone (P4) for decidualization. ..

    Analogues:

    Article Title: Protein kinase inhibition differentially regulates organic cation transportThis article is one of a selection of papers published in a special issue celebrating the 125th anniversary of the Faculty of Medicine at the University of Manitoba.
    Article Snippet: .. D ow nl oa de d fr om w w w .n rc re se ar ch pr es s. co m b y U ni ve rs ity o f Q ue en sl an d on 1 1/ 15 /1 4 Fo r pe rs on al u se o nl y. mU/mL), 8-bromoadenosine 3’,5’-cyclic monophosphate sodium salt (8-Br-cAMP) (100 mmol/L), N6,2’-O-dibutyryladenosine 3’,5’-cyclic monophosphate sodium salt (dibutyryl cAMP) (100 mmol/L), forskolin (1–10 mmol/L), and staurosporine (6 nmol/L) and allowed to incubate at 37 8C in an incubator (Thermo Forma Series II water jacketed) for 30 min for insulin and cAMP analogues and 60 min for forskolin and staurosporine. ..

    Article Title: Protein kinase inhibition differentially regulates organic cation transport
    Article Snippet: .. Before each assay, medium was removed from the cells; attached cells were washed with PBS and replaced with fresh buffer containing insulin (0.8–20 mU/mL), 8-bromoadenosine 3′,5′-cyclic monophosphate sodium salt (8-Br-cAMP) (100 μmol/L), N 6 ,2′- O -dibutyrylade-nosine 3′,5′-cyclic monophosphate sodium salt (dibutyryl cAMP) (100 μmol/L), forskolin (1–10 μmol/L), and staurosporine (6 nmol/L) and allowed to incubate at 37 °C in an incubator (Thermo Forma Series II water jacketed) for 30 min for insulin and cAMP analogues and 60 min for forskolin and staurosporine. ..

    Radio Immunoprecipitation:

    Article Title: Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small-Cell Lung Cancer
    Article Snippet: .. RPMI1640, fetal bovine serum (FBS) were from Invitrogen (Carlsbad, CA); 8-bromoadenosine 3′,5′ cyclic monophosphate (cAMP), 3-isobutyl-1-methylxanthine (IBMX) and Bradford Reagent were from Sigma (St Louis, MO); monoclonal anti-NSE antibody was from DAKO (Carpinteria, CA); monoclonal glyceraldehyde-3-dehydrogenase, polyclonal Akt1,2,3 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA); siRNA-Erk1/2, monoclonal antiphospho Akt (S473), anti-Erk 1/2, and antiphosphoErk 1/2(T202/Y204) were from Cell Signaling Technology (Danvers, MA); and radio-immunoprecipitation assay (RIPA) lysis buffer was from Upstate Cell Signaling Solution (Lake Placid, NY). .. U0126 (used at a final concentration of 10 μM) was from Calbiochem (San Diego, CA); LY294002 (used at final concentration of 20 μM) was from Cayman Chemical (Ann Arbor, MI); and Interfere-in Transfection Reagent was from Polyplus-Transfection (Illkirch, France).

    Lysis:

    Article Title: Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small-Cell Lung Cancer
    Article Snippet: .. RPMI1640, fetal bovine serum (FBS) were from Invitrogen (Carlsbad, CA); 8-bromoadenosine 3′,5′ cyclic monophosphate (cAMP), 3-isobutyl-1-methylxanthine (IBMX) and Bradford Reagent were from Sigma (St Louis, MO); monoclonal anti-NSE antibody was from DAKO (Carpinteria, CA); monoclonal glyceraldehyde-3-dehydrogenase, polyclonal Akt1,2,3 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA); siRNA-Erk1/2, monoclonal antiphospho Akt (S473), anti-Erk 1/2, and antiphosphoErk 1/2(T202/Y204) were from Cell Signaling Technology (Danvers, MA); and radio-immunoprecipitation assay (RIPA) lysis buffer was from Upstate Cell Signaling Solution (Lake Placid, NY). .. U0126 (used at a final concentration of 10 μM) was from Calbiochem (San Diego, CA); LY294002 (used at final concentration of 20 μM) was from Cayman Chemical (Ann Arbor, MI); and Interfere-in Transfection Reagent was from Polyplus-Transfection (Illkirch, France).



    Similar Products

    bromoadenosine 3  (Thermo Fisher)
    94
    Thermo Fisher bromoadenosine 3
    Bromoadenosine 3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromoadenosine+3/8-Bromoadenosine-3'%2C5'-cyclic+monophosphate/pm41699681-111-14-17
    Average 94 stars, based on 1 article reviews
    bromoadenosine 3 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    bromoadenosine 3  (Biolog Inc)
    86
    Biolog Inc bromoadenosine 3
    Bromoadenosine 3, supplied by Biolog Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromoadenosine+3/3+5+8+bromoadenosine+cyclic/pm42068548-324-56-62
    Average 86 stars, based on 1 article reviews
    bromoadenosine 3 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    bromoadenosine 3  (MedChemExpress)
    94
    MedChemExpress bromoadenosine 3
    Bromoadenosine 3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromoadenosine+3/8-Bromoadenosine/pmc12964726-139-53-48
    Average 94 stars, based on 1 article reviews
    bromoadenosine 3 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    bromoadenosine 3  (Nacalai)
    86
    Nacalai bromoadenosine 3
    Proteomic analysis of Ishikawa-sEVs. A Timeline of the experimental protocol for hormonal treatment of Ishikawa cells. B Concentration of sEVs (µg/mL; total protein amount of sEVs per volume of conditioned culture medium) in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). C Dot plots showing the expression levels of proteins identified in Ishikawa-sEVs (915 proteins) ranked in descending order of intensity. Canonical sEV marker proteins are highlighted in each plot. D Number of proteins identified in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). E Total protein intensity in the two groups. Data are presented as median (bold horizontal line) with interquartile range (box). Statistical significance was assessed using the Mann–Whitney U -test (***, P < 0.001). F t-SNE plot showing clustering of proteomic profiles from eight samples. G Scatter plot of 915 proteins identified in Ishikawa-sEVs, displaying protein intensities in I-Ishikawa-sEVs against P-Ishikawa-sEVs. DEPs are colour-coded: red indicates upregulation and blue indicates downregulation in I-Ishikawa-sEVs compared with P-Ishikawa-sEVs. The labelled proteins are commonly differentially expressed in both UF-sEVs and Ishikawa-sEVs during the implantation phase. H Dot plots showing the expression levels of galectin-3 in each sample. Data are presented as mean ± SD. Statistical significance was assessed using the Mann–Whitney U -test (*, P < 0.05; **, P < 0.01)). Abbreviations: FBS, Foetal bovine serum; E 2 , β-estradiol; P 4 , Progesterone; <t>cAMP,</t> <t>8-bromoadenosine</t> <t>3′,5′-cyclic</t> monophosphate; P-Ishikawa-sEVs, Proliferative-phase Ishikawa-sEVs; I-Ishikawa-sEVs, Implantation-phase Ishikawa-sEVs; DEP, Differentially expressed protein
    Bromoadenosine 3, supplied by Nacalai, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromoadenosine+3/2+3+5+cyclic+dibutyryladenosine+n6+o/pmc12831369-47-57-62
    Average 86 stars, based on 1 article reviews
    bromoadenosine 3 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    8-bromoadenosine 3’,5’-cyclic monophosphate sodium salt (camp)  (Millipore)
    90
    Millipore 8-bromoadenosine 3’,5’-cyclic monophosphate sodium salt (camp)
    Proteomic analysis of Ishikawa-sEVs. A Timeline of the experimental protocol for hormonal treatment of Ishikawa cells. B Concentration of sEVs (µg/mL; total protein amount of sEVs per volume of conditioned culture medium) in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). C Dot plots showing the expression levels of proteins identified in Ishikawa-sEVs (915 proteins) ranked in descending order of intensity. Canonical sEV marker proteins are highlighted in each plot. D Number of proteins identified in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). E Total protein intensity in the two groups. Data are presented as median (bold horizontal line) with interquartile range (box). Statistical significance was assessed using the Mann–Whitney U -test (***, P < 0.001). F t-SNE plot showing clustering of proteomic profiles from eight samples. G Scatter plot of 915 proteins identified in Ishikawa-sEVs, displaying protein intensities in I-Ishikawa-sEVs against P-Ishikawa-sEVs. DEPs are colour-coded: red indicates upregulation and blue indicates downregulation in I-Ishikawa-sEVs compared with P-Ishikawa-sEVs. The labelled proteins are commonly differentially expressed in both UF-sEVs and Ishikawa-sEVs during the implantation phase. H Dot plots showing the expression levels of galectin-3 in each sample. Data are presented as mean ± SD. Statistical significance was assessed using the Mann–Whitney U -test (*, P < 0.05; **, P < 0.01)). Abbreviations: FBS, Foetal bovine serum; E 2 , β-estradiol; P 4 , Progesterone; <t>cAMP,</t> <t>8-bromoadenosine</t> <t>3′,5′-cyclic</t> monophosphate; P-Ishikawa-sEVs, Proliferative-phase Ishikawa-sEVs; I-Ishikawa-sEVs, Implantation-phase Ishikawa-sEVs; DEP, Differentially expressed protein
    8 Bromoadenosine 3’,5’ Cyclic Monophosphate Sodium Salt (Camp), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromoadenosine+3/8+bromo+camp/pm40592324-282-153-158
    Average 90 stars, based on 1 article reviews
    8-bromoadenosine 3’,5’-cyclic monophosphate sodium salt (camp) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    8-bromoadenosine 3′,5′-cyclic monophosphate sodium salt (camp)  (Millipore)
    90
    Millipore 8-bromoadenosine 3′,5′-cyclic monophosphate sodium salt (camp)
    Proteomic analysis of Ishikawa-sEVs. A Timeline of the experimental protocol for hormonal treatment of Ishikawa cells. B Concentration of sEVs (µg/mL; total protein amount of sEVs per volume of conditioned culture medium) in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). C Dot plots showing the expression levels of proteins identified in Ishikawa-sEVs (915 proteins) ranked in descending order of intensity. Canonical sEV marker proteins are highlighted in each plot. D Number of proteins identified in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). E Total protein intensity in the two groups. Data are presented as median (bold horizontal line) with interquartile range (box). Statistical significance was assessed using the Mann–Whitney U -test (***, P < 0.001). F t-SNE plot showing clustering of proteomic profiles from eight samples. G Scatter plot of 915 proteins identified in Ishikawa-sEVs, displaying protein intensities in I-Ishikawa-sEVs against P-Ishikawa-sEVs. DEPs are colour-coded: red indicates upregulation and blue indicates downregulation in I-Ishikawa-sEVs compared with P-Ishikawa-sEVs. The labelled proteins are commonly differentially expressed in both UF-sEVs and Ishikawa-sEVs during the implantation phase. H Dot plots showing the expression levels of galectin-3 in each sample. Data are presented as mean ± SD. Statistical significance was assessed using the Mann–Whitney U -test (*, P < 0.05; **, P < 0.01)). Abbreviations: FBS, Foetal bovine serum; E 2 , β-estradiol; P 4 , Progesterone; <t>cAMP,</t> <t>8-bromoadenosine</t> <t>3′,5′-cyclic</t> monophosphate; P-Ishikawa-sEVs, Proliferative-phase Ishikawa-sEVs; I-Ishikawa-sEVs, Implantation-phase Ishikawa-sEVs; DEP, Differentially expressed protein
    8 Bromoadenosine 3′,5′ Cyclic Monophosphate Sodium Salt (Camp), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromoadenosine+3/8+bromo+camp/pmc12264733-212-35-41
    Average 90 stars, based on 1 article reviews
    8-bromoadenosine 3′,5′-cyclic monophosphate sodium salt (camp) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Proteomic analysis of Ishikawa-sEVs. A Timeline of the experimental protocol for hormonal treatment of Ishikawa cells. B Concentration of sEVs (µg/mL; total protein amount of sEVs per volume of conditioned culture medium) in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). C Dot plots showing the expression levels of proteins identified in Ishikawa-sEVs (915 proteins) ranked in descending order of intensity. Canonical sEV marker proteins are highlighted in each plot. D Number of proteins identified in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). E Total protein intensity in the two groups. Data are presented as median (bold horizontal line) with interquartile range (box). Statistical significance was assessed using the Mann–Whitney U -test (***, P < 0.001). F t-SNE plot showing clustering of proteomic profiles from eight samples. G Scatter plot of 915 proteins identified in Ishikawa-sEVs, displaying protein intensities in I-Ishikawa-sEVs against P-Ishikawa-sEVs. DEPs are colour-coded: red indicates upregulation and blue indicates downregulation in I-Ishikawa-sEVs compared with P-Ishikawa-sEVs. The labelled proteins are commonly differentially expressed in both UF-sEVs and Ishikawa-sEVs during the implantation phase. H Dot plots showing the expression levels of galectin-3 in each sample. Data are presented as mean ± SD. Statistical significance was assessed using the Mann–Whitney U -test (*, P < 0.05; **, P < 0.01)). Abbreviations: FBS, Foetal bovine serum; E 2 , β-estradiol; P 4 , Progesterone; cAMP, 8-bromoadenosine 3′,5′-cyclic monophosphate; P-Ishikawa-sEVs, Proliferative-phase Ishikawa-sEVs; I-Ishikawa-sEVs, Implantation-phase Ishikawa-sEVs; DEP, Differentially expressed protein

    Journal: Cell Communication and Signaling : CCS

    Article Title: Galectin-3 in endometrial small extracellular vesicles promotes cytotrophoblast cell fusion during the implantation phase

    doi: 10.1186/s12964-025-02586-1

    Figure Lengend Snippet: Proteomic analysis of Ishikawa-sEVs. A Timeline of the experimental protocol for hormonal treatment of Ishikawa cells. B Concentration of sEVs (µg/mL; total protein amount of sEVs per volume of conditioned culture medium) in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). C Dot plots showing the expression levels of proteins identified in Ishikawa-sEVs (915 proteins) ranked in descending order of intensity. Canonical sEV marker proteins are highlighted in each plot. D Number of proteins identified in the two groups. Data are presented as mean ± SD. Statistical significance was assessed using the Student’s t -test (ns, not significant). E Total protein intensity in the two groups. Data are presented as median (bold horizontal line) with interquartile range (box). Statistical significance was assessed using the Mann–Whitney U -test (***, P < 0.001). F t-SNE plot showing clustering of proteomic profiles from eight samples. G Scatter plot of 915 proteins identified in Ishikawa-sEVs, displaying protein intensities in I-Ishikawa-sEVs against P-Ishikawa-sEVs. DEPs are colour-coded: red indicates upregulation and blue indicates downregulation in I-Ishikawa-sEVs compared with P-Ishikawa-sEVs. The labelled proteins are commonly differentially expressed in both UF-sEVs and Ishikawa-sEVs during the implantation phase. H Dot plots showing the expression levels of galectin-3 in each sample. Data are presented as mean ± SD. Statistical significance was assessed using the Mann–Whitney U -test (*, P < 0.05; **, P < 0.01)). Abbreviations: FBS, Foetal bovine serum; E 2 , β-estradiol; P 4 , Progesterone; cAMP, 8-bromoadenosine 3′,5′-cyclic monophosphate; P-Ishikawa-sEVs, Proliferative-phase Ishikawa-sEVs; I-Ishikawa-sEVs, Implantation-phase Ishikawa-sEVs; DEP, Differentially expressed protein

    Article Snippet: Subsequently, the cells were divided into two groups: a proliferative-phase Ishikawa cell group (P-Ishikawa), cultured in basal medium with 10 –8 M E 2 , and an implantation-phase Ishikawa cell group (I-Ishikawa), cultured in basal medium with 10 –8 M E 2 , 10 –7 M progesterone (P 4 ; #P8783-1G, Sigma-Aldrich), 2.5 × 10 –4 M 8-bromoadenosine 3′,5′-cyclic monophosphate (cAMP; #05450-02, Nacalai Tesque), and 10 –5 M XAV939 (#247–00951, FUJIFILM Wako, Osaka, Japan).

    Techniques: Concentration Assay, Expressing, Marker, MANN-WHITNEY